Issue 2, 2021

Pt@polydopamine nanoparticles as nanozymes for enhanced photodynamic and photothermal therapy

Abstract

Polydopamine nanoparticles were used to stabilize a nano-Pt catalyst to relieve tumour hypoxia in photodynamic therapy (PDT). Polydopamine not only provides a platform for carrying nano-Pt and photosensitizers but is also used as a photothermal reagent for photothermal therapy (PTT). The system presented an enhanced anti-tumor therapy effect through a combined PDT and PTT mechanism.

Graphical abstract: Pt@polydopamine nanoparticles as nanozymes for enhanced photodynamic and photothermal therapy

Supplementary files

Article information

Article type
Communication
Submitted
08 Nov 2020
Accepted
19 Nov 2020
First published
26 Nov 2020

Chem. Commun., 2021,57, 255-258

Pt@polydopamine nanoparticles as nanozymes for enhanced photodynamic and photothermal therapy

H. Cao, Y. Yang, M. Liang, Y. Ma, N. Sun, X. Gao and J. Li, Chem. Commun., 2021, 57, 255 DOI: 10.1039/D0CC07355E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements